Clinical Trial Update: Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 1/2 study evaluating gum arabic as a fetal hemoglobin-inducing agent for sickle cell anemia, with the trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Gum Arabic (arabic gum)

Snippet

Sponsor: Al-Neelain University | Conditions: Sickle Cell Anemia | Phase 1, Phase 2 | Status: COMPLETED